Home › Funds › Ikarian Capital, LLC › BIOA

Ikarian Capital, LLC position in BIOA

BIOAGE LABS INC · Health Care

Ikarian Capital, LLC reported holding 200,000 shares of BIOA (BIOAGE LABS INC) in its Q2 2026 13F filing — a position valued at US$4.9M, representing 0.79% of its reported portfolio and ranking #42 among its reported holdings. Ikarian Capital, LLC first reported this position in Q2 2026.

Latest position (Q2 2026)200.00K sh
Reported value held$4.90M
Portfolio Weight0.79%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Ikarian Capital, LLC's BIOA position evolved

Ikarian Capital, LLC first disclosed a stake in BIOA in Q2 2026 at 200,000 shares (US$4.9M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 200.00K $4.90M New

About BIOA and 13F data

BIOA (BIOAGE LABS INC) is a Health Care company. 78 other funds we track also report a position in BIOA — the largest reported positions include a16z Capital Management, L.L.C. (US$79.2M), Cormorant Asset Management, LP (US$58.6M), Sofinnova Investments, Inc. (US$56.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIOA

All BIOA fund holders →

FAQ

How long has Ikarian Capital, LLC held BIOA?

Ikarian Capital, LLC has disclosed BIOA holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Ikarian Capital, LLC's current position in BIOA?

As of Q2 2026, Ikarian Capital, LLC holds 200.00K shares of BIOA (BIOAGE LABS INC), valued at $4.90M, representing 0.79% of its reported portfolio and ranking #42.

Has Ikarian Capital, LLC been buying or selling BIOA?

In the latest 13F filing (Q2 2026), Ikarian Capital, LLC newly opened its position in BIOA.

Which other funds hold BIOA?

Other major institutional holders of BIOA include a16z Capital Management, L.L.C., Cormorant Asset Management, LP, Sofinnova Investments, Inc., among 78 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.